CD19 and melanoma: To characterize the activity of primary murine CD19 (mCD19) CAR T cells against solid tumors that uniformly express mCD19, we first stably expressed mCD19 and a TurboRFP/Renilla luciferase (TR) fusion protein in the B16 mouse melanoma cell line (Figure S1).